These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 630114)

  • 41. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
    Schwarze EW
    Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early diagnosis of low grade malignant lymphoma and chronic lymphocytic leukaemia. Verification of morphologically suspected malignancy in blood lymphocytes by flow cytometry.
    Schleiffenbaum BE; Rüegg R; Zimmermann D; Fehr J
    Eur J Haematol; 1996 Nov; 57(5):341-8. PubMed ID: 9003474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
    Moccia F; Casti P; Morra L
    Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colchicine ultrasensitivity of lymphocytes in chronic lymphocytic leukaemia.
    Wetherley-Mein G; Thomson AE; O'Connor TW; Peel WE; Singh AK
    Br J Haematol; 1983 May; 54(1):111-20. PubMed ID: 6849831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recirculation of lymphocytes in patients with malignant lymphatic systemic diseases].
    Bremer K; Schick P; Wack O; Theml H; Brass B; Heimpel H
    Blut; 1972 Apr; 24(4):215-25. PubMed ID: 5067297
    [No Abstract]   [Full Text] [Related]  

  • 46. Some data on the proliferative activity of prolymphocytic leukemia.
    Donhuijsen K; Richter HJ
    Klin Wochenschr; 1980 Mar; 58(5):259-60. PubMed ID: 6931266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correlations between lymphocyte subpopulation and stage of disease in chronic lymphatic leukemia of Rai].
    Heilmann E; Nordiek R
    Haematologia (Budap); 1977; 11(3-4):289-95. PubMed ID: 311309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia.
    Mendelsohn J; Nordberg J
    J Clin Invest; 1979 Jun; 63(6):1124-32. PubMed ID: 221534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proliferation patterns of peripheral blood lymphocytes in CLL patients: cytophotometric and microfluorimetric study.
    Kozinets GI; Kotelnikov VM; Poljanskaja AM; Goldberg VE; Gusejnov TN
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):97-110. PubMed ID: 2439422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 51. Association of aberrant transcortin levels with HLA antigens of the B and C loci: high transcortin levels are frequently found in patients with lymphatic leukemia, hairy cell leukemia, or non-Hodgkin lymphoma.
    De Moor P; Louwagie A
    J Clin Endocrinol Metab; 1980 Oct; 51(4):868-72. PubMed ID: 6932403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuclear clefts in chronic lymphocytic leukaemia. A light microscopic and ultrastructural study of a new prognostic parameter.
    Ralfkiaer E; Geisler C; Hansen MM; Hou-Jensen K
    Scand J Haematol; 1983 Jan; 30(1):5-12. PubMed ID: 6836222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphoid nodules of bone marrow: normal and abnormal.
    Rywlin AM; Ortega RS; Dominguez CJ
    Blood; 1974 Mar; 43(3):389-400. PubMed ID: 4130097
    [No Abstract]   [Full Text] [Related]  

  • 54. Investigation of a new parameter in chronic lymphocytic leukemia: the percentage of large peripheral lymphocytes determined by the Hemalog D. Prognostic significance.
    Binet JL; Vaugier G; Dighiero G; d'Athis P; Charron D
    Am J Med; 1977 Nov; 63(5):683-8. PubMed ID: 930943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired recirculation of autotransfused blood lymphocytes via thoracic duct lymph in patients with chronic lymphoid leukemia.
    Bremer K; Wack O; Schick P
    Biomedicine; 1973 Sep; 18(5):393-400. PubMed ID: 4800554
    [No Abstract]   [Full Text] [Related]  

  • 56. The binding of ouabain to normal and chronic lymphocytic leukemic lymphocytes.
    Wiley JS; Kraft N; Cooper IA
    Blood; 1979 Nov; 54(5):994-1000. PubMed ID: 315246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A new parameter for chronic lymphocytic leukemia : determination of the large lymphocytes by means of Hemalog D (author's transl)].
    Vaugier G; Dighiero G; Charron D; Natali JC; Leporrier M; Debré P; d'Athis P; Binet JL
    Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):311-5. PubMed ID: 704345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
    Ukaejiofo EO; Sagoe AS; Osunkoya BO
    Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antioxidant status, erythrocyte membrane lipid peroxidation and osmotic fragility in malignant lymphoma patients.
    Abou-Seif MA; Rabia A; Nasr M
    Clin Chem Lab Med; 2000 Aug; 38(8):737-42. PubMed ID: 11071066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.